The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Predictors of treatment response in chronic spontaneous urticaria
Open accessAbstract
The current therapeutic algorithm for chronic spontaneous urticaria (CSU), endorsed by the international guideline, entails treatment escalation from second‐generation H 1‐antihistamines (sgAHs) to omalizumab and cyclosporine until complete response is achieved. Recently, several predictors of response to these treatment options have been described. Here, we discuss the most promising predictors of response and nonresponse to these treatments in CSU. A systematic search was performed by two independent researchers using the MEDLINE/PubMed database with specific keywords and 73 studies included in the review. Levels of evidence were categorized as strong (robust predictors), weak (emerging predictors) or no association, based on the outcome and number of studies available. High disease activity, high levels of C‐reactive protein and D‐dimer are robust predictors for a poor or no response to sgAHs. Poor or no response to omalizumab is robustly predicted by low serum levels of total IgE. A good response to cyclosporine is robustly predicted by a positive basophil histamine release assay, whereas low total IgE is an emerging predictor. The response to treatment with sgAHs, omalizumab and cyclosporine can be predicted by the use of markers that are readily available in routine clinical practice. Further studies are needed to confirm these predictors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fricke, J., Ávila, G., Keller, T., Weller, K., Lau, S., Maurer, M., Zuberbier, T., & Keil, T. (2020) · Allergy · doi:10.1111/all.14037 · Cited by 465
Self-citationThe burden of chronic spontaneous urticaria is substantial: Real‐world evidence from ASSURE ‐ CSU
Maurer, M., Abuzakouk, M., Bérard, F., Canonica, W., Oude Elberink, H., Giménez‐Arnau, A., Grattan, C., Hollis, K., Knulst, A., Lacour, J. ‐., et al. (2017) · Allergy · doi:10.1111/all.13209 · Cited by 383 · cited 1×
“J Invest Dermatol 2008;128(8):19561963.”
Self-citationMaurer, M., Staubach, P., Raap, U., Richter‐Huhn, G., Bauer, A., Ruëff, F., Jakob, T., Yazdi, A. S., Mahler, V., Wagner, N., et al. (2017) · Clinical & Experimental Allergy · doi:10.1111/cea.12900 · Cited by 131
Self-citationPsychiatric comorbidity in chronic urticaria patients: a systematic review and meta-analysis
Konstantinou, G. N., & Konstantinou, G. N. (2019) · Clinical and Translational Allergy · doi:10.1186/s13601-019-0278-3 · Cited by 110
Cited by
Zuberbier, T., Abdul Latiff, A. H., Abuzakouk, M., Aquilina, S., Asero, R., Baker, D., Ballmer‐Weber, B., Bangert, C., Ben‐Shoshan, M., Bernstein, J. A., et al. (2022) · Allergy · doi:10.1111/all.15090 · Cited by 1,263
Self-citationKolkhir, P., Giménez-Arnau, A. M., Kulthanan, K., Peter, J., Metz, M., & Maurer, M. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00389-z · Cited by 382
Self-citationAutoimmune chronic spontaneous urticaria
Kolkhir, P., Muñoz, M., Asero, R., Ferrer, M., Kocatürk, E., Metz, M., Xiang, Y.-K., & Maurer, M. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.04.010 · Cited by 301
Self-citationA Patient Charter for Chronic Urticaria
Maurer, M., Albuquerque, M., Boursiquot, J.-N., Dery, E., Giménez-Arnau, A., Godse, K., Guitiérrez, G., Kanani, A., Lacuesta, G., McCarthy, J., et al. (2024) · Advances in Therapy · doi:10.1007/s12325-023-02724-6 · Cited by 10
Self-citation
Metadata
- Authors
- Fok, J. S., Kolkhir, P., Church, M. K., & Maurer, M.
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 2021-02-27
- Volume
- 76
- Issue
- 10
- Pages
- 2965-2981
- ISSN
- 0105-4538 (ISSN-L)
- 1398-9995
- OpenAlex
- W3126817223
- Cited by
- 163
- References
- 4
- FWCI
- 16.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Predictors of treatment response in chronic spontaneous urticaria. https://app.cochat.ai/papers/10.1111/all.14757
- The paper
- Fok, J. S., Kolkhir, P., Church, M. K., & Maurer, M. (2021). Predictors of treatment response in chronic spontaneous urticaria. Allergy. https://doi.org/10.1111/all.14757
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.